The indirect costs results were scarcely significant compared with the direct costs, as they represent on average less than 2% of the total.
← all excerpts
Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patients.
1
—
—